Naloxone Hydrochloride Spray
Product Images NDC 50090-6710

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 50090-6710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

A line graph depicting naloxone plasma concentration (ng/mL) over time, measured in hours postdose. The graph compares plasma levels following different naloxone dosages and administration routes, including nasal sprays with various mg amounts and injection. Each line is labeled with dose and spray volume details.*

FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

This graph shows naloxone plasma concentration (ng/mL) over time (hours postdose) comparing different dosages and administration routes: 2 mg nasal spray in one nostril, 4 mg nasal spray in each nostril, 4 mg nasal spray at higher concentration (0.1 mL of 40 mg/mL) in one nostril, 8 mg nasal spray at higher concentration in each nostril, and 0.4 mg intramuscular (IM) injection. The graph illustrates increasing plasma levels with higher doses and routes over a 1-hour postdose timeframe.*

FDA Label Image

Step 3 (2y2 Step 3)

An instructional illustration showing a hand holding a nasal spray device with labeled parts: the nozzle and the plunger. The image highlights how to hold the spray for proper use.*

FDA Label Image

Step 4 (2y2 Step 4)

Black and white illustration showing a person lying down while another person administers a nasal spray into the person's nostril using their thumb and forefinger to hold the nasal spray device, with one hand supporting the patient's head.*

FDA Label Image

Step 5 (2y2 Step 5)

An instructional illustration showing a hand holding a nasal spray device and administering the spray into a nostril. The device is depicted spraying fluid with dotted lines indicating the spray direction. The spray device is shaped ergonomically for nasal use.*

FDA Label Image

Step 7 (2y2 Step 7)

Illustration showing a person positioned on their side with one knee bent to stop the body from rolling onto the stomach and a hand supporting the head. The diagram includes labels indicating the hand supports the head and the knee stops the body from rolling onto the stomach.*

FDA Label Image

Label (Quick Start Image)

NALOXONE HCl Nasal Spray 4 mg label showing dosage form as spray for nasal use. The label includes dosage and storage instructions, manufacturer Padagis, distributor, barcode, and warnings. Illustrated hands demonstrate peeling the label as per the peel here icon.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of naloxone hydrochloride, showing the molecular arrangement of atoms including rings and functional groups characteristic of the compound.*

FDA Label Image

Step 2 (Image 01)

An instructional illustration showing a person using their hands to peel a label or packaging insert, likely to access information or instructions. The image is related to the use of a nasal spray product but does not display specific text details.*

FDA Label Image

Label Image (Lbl500906710)

Label for NALOXONE HYDROCHLORIDE 4 mg nasal spray by A-S Medication Solutions. The 0.1 mL intranasal spray contains 4 mg naloxone HCl, stored at 70 degrees F, packed as two units per pack. It includes warnings to protect from light and not to freeze.*

FDA Label Image

Step 1 (Quick Start Guide Step 1)

An instructional illustration showing a person administering nasal spray to another individual lying down. The person administering supports the head and lifts the upper lip of the recipient, demonstrating proper nasal spray application technique.*

FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

Instructional illustrations showing the use of NALOXONE HYDROCHLORIDE nasal spray 4 mg/.1mL. The first panel identifies the spray device with labeled parts: nozzle and plunger. The second panel depicts administering the spray into a person's nostril while supporting the head. The third panel shows the nasal spray being activated and delivering the medication.*

FDA Label Image

Step 3 (Quick Start Guide Step 3)

An instructional illustration showing a person lying on their side with one hand supporting their head and the opposite knee preventing the body from rolling onto the stomach. This posture is commonly used as a recovery position for airway safety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.